References
1 NCCN Clinical Practice Guidelines in
Oncology. Antiemesis. V1.2019. www.nccn.
org/professionals/physician_gls/default.aspx
(accessed July 2019).
2 Hesketh PJ et al. Antiemetics: American
Society of Clinical Oncology Clinical Practice
Guideline Update. J Clin Oncol 2017;35:3240–61.
3 Hesketh PJ. Prevention and treatment of
chemotherapy-induced nausea and vomiting
in adults. In: UpToDate, UpToDate, Waltham,
MA, 2017. www.uptodate.com/home/index.html
(assessed August 2018).
4 Hartshorn EA. Drug interaction: 1.
General considerations. Ann Pharmacother
2006;40:116–18.
5 Hines LE, Murphy JE. Potentially harmful
drug-drug interactions in the elderly: a review.
Am J Geriatr Pharmacother 2011;9:364–77.
6 Aloxi prescribing information. www.ema.
europa.eu/docs/en_GB/document_library/
EPAR_-_Product_Information/human/000563/
WC500024259.pdf (accessed July 2019).
7 Zofran prescribing information.
www.medicines.org.uk/emc/product/5222/smpc
(accessed July 2019).
8 Akynzeo (netupitant and palonosetron)
prescribing information.
www.ema.europa.eu/docs/en_GB/document_
library/EPAR_-_Product_Information/
human/003728/WC500188432.pdf (accessed
July 2019).
9 Emend prescribing information.
www.ema.europa.eu/docs/en_GB/document_
library/EPAR__Product_Information/
human/000527/WC500026537.pdf (accessed
August 2018).
10 Ivemend prescribing information. www.ema.
europa.eu/docs/en_GB/document_library/
EPAR_-_Product_Information/human/000527/
WC500026537.pdf (accessed July 2019).
11 Varuby (rolapitant) prescribing information.
www.ema.europa.eu/docs/en_GB/document_
library/EPAR_-_Product_Information/
human/004196/WC500228742.pdf (accessed
July 2019).
12 Ponte ML, Keller GA, Di Girolamo G.
Mechanisms of drug induced QT interval
prolongation. Curr Drug Saf 2010;5:44–53.
13 Gridelli C, Aapro M. Factors influencing
the choice of 5-HT3-receptor antagonist
antiemetics: focus on elderly cancer patients.
Support Care Cancer 2004;12:487/96.
14 Gollapudy S, Kumar V, Dhamee MS. A case of
serotonin syndrome precipitated by fentanyl and
ondansetron in a patient receiving paroxetine,
80 | 2019 | hospitalpharmacyeurope.com
duloxetine, and bupropion. J Clin Anesth
2012;24:251–2.
15 Turkel SB, Nadala JG, Wincor MZ. Possible
serotonin syndrome in association with
5-HT(3) antagonist agents. Psychosomatics
2001;42:258–60.
16 Apokyn (apomorphine) prescribing
information. Morristown, NJ: Vernalis
Pharmaceuticals, Inc, June 2006.
17 Stevens AJ, Woodman RJ, Owen H. The effect
of ondansetron on the efficacy of postoperative
tramadol: a systematic review and meta-
analysis of a drug interaction. Anaesthesia
2015;70:209–18.
18 Villikka K, Kivistö KT, Neuvonen PJ. The effect
of rifampin on the pharmacokinetics of oral and
intravenous ondansetron. Clin Pharmacol Ther
1999;65:377–81.
19 Rapoport B, Smit T. Clinical pharmacology
of neurokinin-1 receptor antagonists for the
treatment of nausea and vomiting associated
with chemotherapy. Expert Opin Drug Saf
2017;16:697–710.
20 Jordan K et al. International antiemetic
guidelines on chemotherapy induced
nausea and vomiting (CINV): content and
implementation in daily routine practice. Eur
J Pharmacol 2014;722:197–202.
21 Schwartzberg L et al. No evidence of
increased cyclophosphamide toxicity associated
with the antiemetic agent NEPA, a fixed-dose
combination of netupitant and palonosetron.
Blood 2013;122:2949.
22 Aapro M et al. No signals of increased toxicity
after concomitant administration of NEPA with
etoposide or docetaxel: pooled safety data
analysis from 4 pivotal studies. Support Care
Cancer 2016;24 (Suppl 1):S79.
23 Tarsy D, Baldessarini RJ, Tarazi FI. Effects
of newer antipsychotics on extrapyramidal
function. CNS Drugs 2002;16:23–45.
24 Zyprexa (olanzapine) prescribing information.
Indianapolis, IN: Eli Lilly and Company; July
2015.
25 Albers LJ et al. Low-dose fluvoxamine as an
adjunct to reduce olanzapine therapeutic dose
requirements: a prospective dose-adjusted drug
interaction strategy. J Clin Psychopharmacol
2005;25:170–4.
26 Dexamethasone prescribing information.
Columbus, OH: Roxane Laboratories Inc;
February 2015.